🇺🇸 FDA
Patent

US 9394352

Immunogenic POTE peptides and methods of use

granted A61KA61K2039/55516A61K2039/55522

Quick answer

US patent 9394352 (Immunogenic POTE peptides and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/55516, A61K2039/55522, A61K2039/55538, A61K2039/57